NCT01225601
- Conditions
- Adult Pulmonary Langerhans Cell Histiocytosis, Hemic and Lymphatic Diseases, Histiocytosis, +5 more
- Locations
-
- Hôpital Saint Louis Paris, France
Clinical trial condition
Histiocytosis, Langerhans-Cell
Explore clinical trials studying Histiocytosis, Langerhans-Cell. Study availability and eligibility vary by location and protocol.
61 public trials
19 recruiting studies
Histiocytosis, Langerhans-Cell trial results
Completed
Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH
NCT00588536
- Conditions
- Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Completed
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
NCT00890747
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
- Locations
-
- Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
- Northwestern University Chicago, Illinois, United States
- AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States
NCT03155620
- Conditions
- Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, +99 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
Active, Not Recruiting
Lenalidomide for Adult Histiocyte Disorders
NCT02523040
- Conditions
- Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +13 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
NCT04284774
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +102 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
Active, Not Recruiting
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
NCT03213652
- Conditions
- Advanced Malignant Solid Neoplasm, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +82 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Active, Not Recruiting
Pediatric Long-Term Follow-up and Rollover Study
NCT03975829
- Conditions
- Anaplastic Astrocytoma, Anaplastic Ganglioglioma, Anaplastic Oligodendroglioma, +62 more
- Locations
-
- Phoenix Children s Hospital Phoenix, Arizona, United States
- Childrens National Hospital Washington D.C., District of Columbia, United States
- Nicklaus Childrens Hospital Miami, Florida, United States
- Indiana Uni School of Medicine Indianapolis, Indiana, United States
Active, Not Recruiting
Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)
NCT04195555
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, Female Urogenital Diseases, +80 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
Active, Not Recruiting
Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders
NCT02425904
- Conditions
- Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
- Locations
-
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Children's Hospital of Los Angeles Los Angeles, California, United States
- University of California San Francisco Medical Center San Francisco, California, United States